Search For "monoclonal antibody therapy"
New treatment for atopic dermatitis shows promising result
Updated : 3 years, 5 months ago IST
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
Read More
Doctors shouldn't practice unethical, immoral, unscientific COVID-19 treat
Updated : 4 years, 4 months ago IST
New Delhi [India], January 24 (ANI): India's top virologist, Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific"
Read More
Monoclonal antibodies prevent severe disease and deaths in high-risk patie
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], November 3 (ANI): Monoclonal Antibody therapy has been proven to be effective in reducing disease severity and chances of death in high-risk individuals infected with the Delta variant of COVID-19 by 100 per cent, as per a study by AIG Hospitals.
Read More
Efficient manufacturing system needed to lower cost of Monoclonal antibody
Updated : 4 years, 12 months ago IST
New Delhi [India], May 30 (ANI): The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment of COVID-19, can be lowered if a very efficient system for its manufacturing is developed, said Dr Nirmal K Ganguly, former Director-General
Read More
Novel monoclonal antibody therapy cuts LDL cholesterol by half in high-ris
Updated : 5 years, 6 months ago IST
Washington [US], November 16 (ANI): The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 per cent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from th
Read More
This drug combo helps soft-tissue cancer survival
Updated : 8 years, 9 months ago IST
Washington D.C, Jul 21 (ANI): Adding a novel monoclonal antibody therapy to traditional chemotherapy can help make people more likely to survive advanced sarcoma, a lethal soft-tissue cancer, by nearly a year, suggests a recent study.
Read More